Cholinergic Drug Effects: Identifying the Exception
The correct answer is A) Tachycardia and hypertension - these are NOT typical effects of cholinergic drugs. Cholinergic drugs produce muscarinic and nicotinic receptor stimulation, which characteristically causes bradycardia and hypotension, not tachycardia and hypertension 1.
Understanding Cholinergic Drug Effects
Cholinergic drugs increase acetylcholine activity at muscarinic and nicotinic receptors, producing predictable clinical manifestations:
Cardiovascular Effects (Why A is the Exception)
Cholinergic drugs cause bradycardia and hypotension through muscarinic receptor activation, not tachycardia and hypertension 1. The guidelines on nerve agent intoxication (which are cholinergic agonists) clearly document that after a brief initial nicotinic phase lasting only minutes with sublethal doses, the dominant effect is "severe cardiac depression manifested as bradycardia and hypotension caused by parasympathetic overstimulation of the muscarinic receptors" 1.
The Correct Cholinergic Effects (Options B-E)
All other options listed ARE genuine cholinergic effects:
B) Lacrimation and salivation - Classic muscarinic effects from secretory gland hyperstimulation 1. The guidelines specifically list "excessive lacrimation, salivation" as direct consequences of acetylcholine accumulation at muscarinic sites 1.
C) Nausea, vomiting, and diarrhea - Result from gastrointestinal muscarinic hyperstimulation causing "hypermotility causing nausea, vomiting, abdominal cramps, and severe diarrhea" 1.
D) Sweating - Muscarinic effect secondary to ganglionic stimulation, explicitly documented as "perspiration (muscarinic effects secondary to ganglionic stimulation by acetylcholine)" 1.
E) Urinary frequency - Muscarinic effect on the urinary tract causing "urinary incontinence" 1.
Clinical Pitfall to Avoid
Do not confuse the brief initial nicotinic phase with the dominant cholinergic effect. With nerve agents (potent cholinergic drugs), there may be a transient period of "cardiac overstimulation resulting in hypertension and sinus tachycardia" lasting only minutes, attributable to catecholamine release from adrenal medulla stimulation 1. However, this is rapidly followed by the characteristic and sustained muscarinic effects of bradycardia and hypotension. The question asks about cholinergic drug effects generally, which are dominated by muscarinic activation producing bradycardia, not tachycardia.
Anticholinergic Discontinuation Syndrome
When anticholinergic drugs are stopped abruptly, a "cholinergic rebound" occurs with symptoms including "nausea, sweating, and urinary urgency" 2 - demonstrating that blocking cholinergic activity prevents these symptoms, while enhancing it causes them.